Elastomer Series (Component A) Page 1 of 9
MSDS 12/98
****************************MATERIAL SAFETY DATA SHEET****************************
Manufacturer's Name: PRECISION CONVERTING
Street Address: 6650 CONCORD PARK DR
City, State, Zip: HOUSTON, TX 77040
Phone: (713) 934-1650 Fax (713) 934-1655
Emergency Response Phone: 1-800-424-9300
************************SECTION I ?PRODUCT IDENTIFICATION***********************
CHEMICAL FAMILY: Methylene diphenyl diisocyanate (M.D.I.)
TRADE NAME AND SYNONYMS: PC 00, 10, 20, 30, 40, 50, 55, 65, 70, 85 F, 360,
FORMULA: The specific chemical formula for this material is a Trade Secret of PRECISION
CONVERTING
CHEMICAL NAME: Isocyanic Acid, Polymethylenepolyphenylene Ester
SYNONYMS: Polymeric Diphenylmethane Diisocyanate (MDI)
CAS NUMBER: 9016-87-9
FORMULA: Not Applicable
*************SECTION II ?COMPOSITION/INFORMATION INGREDIENTS*************
HAZARDOUS INGREDIENTS
INGREDIENT NAME
CAS NUMBER EXPOSURE LIMITS CONCENTRATION
4,4'-Diphenylmethane
Diisocyanate (MDI)
CAS # 101-68-8 OSHA: .02 ppm Ceiling Upper Bound 22.5%
.20 mg/m3 Ceiling
ACGIH: .005 ppm TWA
.951 mg/m3 TWA
Higher Oligomers of MDI
CAS # 9016-87-9 OSHA: Not established 22.5%
ACGIH: Not established
Diphenylmethane
Diisocyanate (MDI)
CAS # 26447-40-5 OSHA: Not established 5%
ACGIH: Not established
Toluene Diisocyanate (TDI) OSHA: PEL 0.02 ppm Ceiling Less than 1%
CAS #26471-62-5 ACGIH: .005 ppm TWA
**********************SECTION III ?HAZARDS IDENTIFICATION*************************
EMERGENCY OVERVIEW:
? WARNING! May cause eye, skin, and respiratory tract irritation. Harmful if inhaled; may
cause allergic respiratory reaction, may cause allergic skin reaction, and may cause lung
damage. Toxic gases/fumes are given off during burning or thermal decomposition.
Elastomer Series (Component A) Page 2 of 9
MSDS 12/98
(continued)
POTENTIAL HEALTH EFFECTS:
ROUTES OF ENTRY:
SKIN: Contact from liquid and aerosols (spray application)
INHALATION: Although MDI is low in volatility, an inhalation hazard can exist from MDI
aerosols or vapors formed during heating, foaming or spraying. Individuals that are
sensitized to TDI exposure may result in allergic respiratory reactions.
HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE:
ACUTE INHALATION: MDI/TDI vapors or mist at concentrations above the TLV can irritate
(burning sensation) the mucous membranes in the respiratory tract (nose, throat, and lungs)
causing runny nose, sore throat, coughing, chest discomfort, shortness of breath and
reduced lung function (breathing obstruction). Persons with a preexisting, nonspecific
bronchial hyperactivity can respond to concentrations below the TLV with similar symptoms
as well as asthma attack. Exposure well above the TLV may lead to bronchitis, bronchial
spasm and pulmonary edema (fluid in lungs). These effects are usually reversible. Chemical
or hypersensitive pneumonitis, with flu-like symptoms (e.g., fever, and chills) has also been
reported. These symptoms can be delayed up to several hours after exposure.
CHRONIC INHALATION: As a result of previous repeated overexposures or a single large
dose, certain individuals develop isocyanate at levels well below the TLV. These symptoms,
which can include chest tightness, wheezing, cough, shortness of breath or asthma attack,
could be immediate or delayed (up to several hours after exposure), similar to many non-
specific asthmatic responses. There are reports that once sensitized an individual can
experience these symptoms upon exposure to dust, cold air or other irritants. This increased
lung sensitivity can persist for weeks and in severe cases for several years. Overexposure to
isocyanates has also been reported to cause lung damage, (including decrease in lung
function) which may be permanent. Sensitization can either be temporary or permanent.
ACUTE SKIN CONTACT: Isocyanates react with skin protein and moisture and can cause
irritation, which may include the following symptoms; reddening, swelling, rash, scaling or
blistering. Cured material is difficult to remove.
CHRONIC SKIN CONTACT: Prolonged contact can cause reddening, swelling, rash, scaling,
blistering, and in some cases, skin sensitization. Individuals who have skin sensitization can
develop these symptoms from contact with liquid vapors. Animal tests have indicated that
respiratory sensitization can result from skin contact with MDI. This data reinforces the need
to prevent skin contact with MDI (see Toxicological Information, SENSITIZATION).
ACUTE EYE CONTACT: Liquid, aerosols or vapors are irritating and can cause tearing,
reddening and swelling. If left untreated, corneal damage can occur and injury is slow to
heal. However, damage is usually reversible (see First Aid Measures for treatment).
ACUTE INGESTION: Can result in irritation and corrosive action in the mouth, stomach tissue
and digestive tract. Symptoms can include sore throat, abdominal pain, nausea, vomiting
and diarrhea.
CARCINOENICITY: Neither MDI nor polymeric MDI are listed by the NTP, IARC or regulated
by OSHA as carcinogens.
NTP: Not listed
IARC: Not listed
OSHA: Not regulated
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Asthma, other respiratory disorders
(bronchitis, emphysema, bronchial hyperactivity), skin allergies, eczema.
CARCINOENICITY : TDI is listed as a carcinogen by IARC (2B) and NTP. TDI has been shown
to cause cancer in lab animals when administered orally. Carcinogenicity through inhalation
(most likely route of industrial exposure) has not been proven.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Asthma, other repiratory disorders
(Bronchitis, emphysema, bronchial hyperactivity), skin allergies, eczema.
Elastomer Series (Component A) Page 3 of 9
MSDS 12/98
***************************SECTION IV ?FIRST AID MEASURES*************************
FIRST AID FOR EYES: Flush with copious amounts of water, preferably, lukewarm water for at
least 15 minutes, holding eyelids open all the time. Refer individual to physician or
ophthalmologist for immediate follow-up.
FIRST AID FOR SKIN: Remove contaminated clothing. Wash affected skin thoroughly with soap
and water. Wash contaminated clothing thoroughly before reuse. For severe exposure, get
under safety shower after removing clothing, then get medical attention. For lesser exposures,
seek medical attention if irritation develops or persists after the area is washed.
FIRST AID FOR INHALATION: Move to an area free from risk of further exposure. Administer
oxygen or artificial respiration if needed. Obtain medical attention. Asthmatic-type symptoms
may develop and may be immediate or delayed up to several hours. Consult physician should
this occur.
FIRST AID FOR INGESTION: DO NOT induce vomiting. Give 1 to 2 cups of milk or water to
drink. DO NOT GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON. Consult
physician.
NOTE TO PHYSICIAN:
EYES: Stain for evidence of corneal injury. If cornea is burned, instaill antibiotic steroid
preparation frequently. Work place vapors have produced reversible corneal epithelial
edema impairing vision.
SKIN: This compound is a known skin sensitizer. Treat symptomatically as for contact
dermatitis or thermal burns. If burned, treat as thermal burn.
INGESTION: Treat symptomatically. There is no specific antidote. Inducing vomiting is
contraindicated because of the irritating nature of this compound.
RESPIRATORY: This compound is a known pulmonary sensitizer. Treatment is essentially
symptomatic. An individual having a skin or pulmonary sensitization reaction to this material
should be removed from exposure to any isocyanate.
**********************SECTION V ?FIRE FIGHTING MEASURES************************
FLASH POINT: 390.0 F (198.8 C) Pensky-Martens Closed
EXTINGUISHING MEDIA: Dry chemical, carbon dioxide, foam, and water spray for large fires.
SPECIAL FIRE FIGHTING PROCEDURES: Full emergency equipment with self contained
breathing apparatus and full protective clothing should be worn by firefighters. During a fire,
MDI vapors and other irritating, highly toxic gases may be generated by thermal decomposition
or combustion (see Reactivity and Stability Section). At temperatures greater than 400 F
(204 C) polymeric MDI can polymerize and decompose which can cause pressure build up in
closed containers. Explosive rupture is possible. Therefore, use cold water to cool
fire-exposed containers.
******************SECTION VI ?ACCIDENTAL RELEASE MEASURES******************
SPILL OR LEAK PROCEDURES: Evacuate and ventilate spill area. Dike spill to prevent entry
into water system. Wear full protective equipment, including respiratory equipment during
clean-up (see Employee Protection Recommendations).
MAJOR SPILL: Call PRECISION CONVERTING at (713) 934-1650. If transportation spill, call
CHEMTREC at 800-424-9300. If temporary control of isocyanate vapor is required, a blanket
of protection foam (available at most fire departments) may be placed over the spill. Large
quantities may be pumped into closed, but not sealed container for disposal.
MINOR SPILL: Absorb isocyanates with sawdust or other absorbents. Shovel into suitable
unsealed containers; transport to well ventilated area (outside) and treat with neutralizing
solution: mixture of water (80%) with non-ionic surfactant Tergitol TMN-10 (20%); or
Elastomer Series (Component A) Page 4 of 9
MSDS 12/98
(continued)
water (90%), concentrated ammonia (3-8%) and detergent (2%). Add about 10 parts of
neutralizer per part of isocyanate with mixing. Allow to stand uncovered for 48 hours to let
CO2 escape.
CLEAN UP: Decontaminate floor with decontamination solution letting stand for at least 15
minutes.
***********************SECTION VII ?HANDLING AND STORAGE************************
STORAGE TEMPERATURE (min./max.): 64 F (18 C)/86 F (30 C)
SHELF LIFE: 6 months
SPECIAL SENSITIVITY: If container is exposed to high heat, 400 F (204 C) it can be pressurized
and possible rupture. MDI reacts slowly with water to form CO2 gas. This gas can cause
sealed containers to expand and possibly rupture.
HANDLING/STORAGE PRECAUTIONS: Store in tightly closed containers to prevent moisture
contamination. Do not reseal if contamination is suspected. Avoid contact with skin and eyes.
Do not breathe aerosols or vapors. Warning properties (irritation of the eyes, nose and throat
or odor) are not adequate to prevent chronic overexposure from inhalation. This material can
produce asthmatic sensitization upon either single inhalation exposure to a relatively high
concentration or upon repeated inhalation exposure to lower concentrations. Exposure to
vapors of heated MDI can be extremely dangerous. Employee education and training in the
safe use and handling of this compound are required under the OSHA Hazard Communication
Standard.
************************SECTION VIII ?PERSONAL PROTECTION**********************
EYE PROTECTION REQUIREMENTS: Liquid chemical goggles. Vapor resistant goggles should
be worn when contact lenses are in use. In a splash hazard environment chemical goggles
should be used in combination with a full-face shield.
SKIN PROTECTION REQUIREMENTS: Permeation resistant gloves (butyl rubber, nitrile rubber,
and polyvinyl alcohol). However, please note that PVA degrades in water. Cover as much of
the exposed skin area as possible with appropriate clothing. If skin creams are used, keep
area covered by the cream to a minimum.
VENTILATION REQUIREMENTS: Local exhaust should be used to maintain levels below the
TLV whenever MDI is processed, heated or spray applied. Standard reference sources
regarding industrial ventilation (i.e., ACGIH Industrial Ventilation) should be consulted for
guidance about adequate ventilation.
RESPIRATOR REQUIREMENTS: Concentrations greater than the TLV can occur when MDI is
sprayed, heated or used in a poorly ventilated area. In such cases, or whenever
concentrations of MDI exceed the TLV or are not known, respiratory protection must be worn.
A supplied air respirator (either positive pressure or continuous flow type) is required. In an
emergency situation, a self-contained breathing apparatus may be used. MDI has poor
warning properties, since the concentration at which MDI can be smelled is substantially higher
than the maximum exposure limit. Observe OSHA regulations for respirator use
(29 CFR 1910.134).
MONITORING: Isocyanate exposure levels must be monitored. Monitoring of airborne
isocyanates in the breathing zone of individuals should become part of the overall employee
exposure characterization program. Monitoring techniques have been developed by NIOSH
and OSHA. Upon request, PRECISION CONVERTING can make available methods, which
are modifications of these NIOSH, and OSHA methods.
Elastomer Series (Component A) Page 5 of 9
MSDS 12/98
(continued)
MEDICAL SURVEILLANCE: Medical supervision of all employees who handle or come in contact
with isocyanates is recommended. These should include pre-employment and periodic
medical. examinations with pulmonary function tests (FEC, FVC as a minimum). Persons with
asthmatic-type conditions, chronic bronchitis, other chronic respiratory diseases or recurrent
skin eczema or sensitization should be excluded from working with isocyanates. Once a
person is diagnosed as sensitized to an isocyanate, no further exposure should be permitted
ADDITIONAL PROTECTIVE MEASURES: Safety showers and eyewash stations should be
available. Educate and train employees in safe use of product. Follow all label instructions.
For additional information, contact PRECISION CONVERTING
****************SECTION IX ?PHYSICAL AND CHEMICAL PROPERTIES***************
PHYSICAL FORM: Liquid
COLOR: Clear
ODOR: Slightly musty odor
ODOR THRESHOLD: Not established
pH: Not established
BOILING POINT: 406 F (208 C) at 5 mm Hg for MDI
MELTING/FREEZING POINT: Below 32 F (0 C) for MDI
VISCOSITY: 1100 cps @ 77 F (25 C)
SOLUBILITY IN WATER: Not soluble. Reacts slowly with water to liberate CO2 gases.
SPECIFIC GRAVITY: 1.24 @ 77 F (25 C)
BULK DENSITY: 9 lbs./gal.
% VOLATILE BY VOLUME: Negligible
VAPOR PRESSURE: Less than 10-5 mm Hg at 77 F (25 C) for MDI
VAPOR DENSITY: 8.5 (MDI) (Air ?1)
**********************SECTION X ?STABILITY AND REACTIVITY************************
STABILITY: This is a stable material
HAZARDOUS POLYMERIZATION: May occur; contact with moisture, other materials, which
react with isocyanates, or temperatures about 400 F (204 C), may cause polymerization.
INCOMPATIBILITIES: Water, amines, strong bases, alcohol's will cause some corrosion to
copper alloys and aluminum.
INSTABILITY CONDITIONS: Contamination with water and high temperatures above 400 F
(204 C).
DECOMPOSITION PRODUCTS: By high heat and fire; carbon monoxide, oxides of nitrogen,
traces of HCN, MDI vapors or aerosols.
********************SECTION XI ?TOXICOLOGICAL INFORMATION*********************
TOXICITY DATA FOR: Diphenylmethane Diisocyanate (Monomeric and Polymeric)
ACUTE TOXICITY:
ORAL LD50: Greater than 15,800 mg/kg (rat)
DERMAL LD50: Greater than 5,010 but less than 7,940 mg/kg (rabbit)
INHALATION LC50: The 4-hour LC50 for polymeric MDI in rats ranges from 370 to 490
mg/m3. The LC50 for monomeric MDI was estimated to be between 172 and 187 mg/m3.
EYE EFFECTS: Slight to moderate irritation.
SKIN EFFECTS: Slight to moderate irritation.
Elastomer Series (Component A) Page 6 of 9
MSDS 12/98
(continued)
SENSITIZATION: MDI has been shown to produce dermal sensitization in laboratory animals.
Evidence of respiratory sensitization has also been observed in guinea pigs. In addition,
there is some evidence suggestive of cross-sensitization between different types of
diisocyanates.
CHRONIC TOXICITY: In a combined chronic inhalation toxicity/oncogenicity study, rats were
exposed to an aerosol of polymeric MDI for 6 hours per day, 5 days per week for one or two
years. The exposure concentrations were 0, 0.2, 1.0 and 6.0 mg/m3. Microscopic
examination of tissues revealed the effects of irritation to the nasal cavity and lungs in
animals exposed to 1.0 and 6.0 mg/m3. The No Observable Effect Level (NOEL) was
0.2 mg/m3.
CARCINOGENICITY: In the study described above (CHRONIC TOXICITY), the occurrence of
pulmonary adenomas and a single pulmonary adenocarcinoma was considered to be related to
MDI. These tumors were observed only in rats exposed to the high concentration of 6.0
mg/m3.
MUTAGENICITY: Positive (Salmonella microsome test with metabolic activation; cell
transformation assay) as well as negative (mouse lymphoma specific locus mutation test with or
without metabolic activation) results have been observed "in vitro". However, MDI was negative
in an "in vivo" (mouse micronucleus) assay.
DEVELOPMENTAL TOXICITY: Rats were exposed to polymeric MDI at air concentrations of 0, 1,
4 and 12 mg/m3 during days 6 ?15 of gestation. Maternal Toxicity (including mortality) was
observed at the highest concentration of 12 mg/m3 accompanied by embryo and fetal toxicity.
However, no eratogenic effects were observed even at this lethal concentration.
**********************SECTION XII ?ECOLOGICAL INFORMATION*********************
ECOLOGY DATA FOR: Diphenylmethane Diisocyanate (Monomeric and Polymeric)
AQUATIC TOXICITY: LC50 ?24 hours (static): Greater than 500 mg/liter for Daphnia magna,
Limnea Stagnalis, and Zebra fish (Brachydanio rerio) for both polymetic and monomeric MDI.
*********************SECTION XIII ?DISPOSAL CONSIDERATIONS********************
WASTE DISPOSAL METHOD: Waste must be disposed of in accordance with federal, state and
local environmental control regulations. Incineration is the preferred method.
EMPTY CONTAINER PRECAUTIONS: Empty containers must be handled with care due to
product residue. Decontaminate containers prior to disposal. Empty decontaminated
containers should be crushed to prevent reuse. DO NOT HEAT OR CUT EMPTY CONTAINER
WITH ELECTRIC OR GAS TORCH (see Fire Fighting Measures and Stability & Reactivity).
Gases may be highly toxic.
TRANSPORTATION EMERGENCIES: Bayer requires that CHEMTREC be immediately notified
at 800-424-9300 when this product is unintentionally released from its container during its
course of distribution, regardless of the amount released. Distribution includes transportation,
storage incidental to transportation, loading and unloading. Such notification must be
immediate and made by the person having knowledge of the release.
******************SECTION XIV ?TRANSPORTATION INFORMATION******************
TECHNICAL SHIPPING NAME: Methylene diphenyl diisocyanate
DOT (DOMESTIC SURFACE)
Elastomer Series (Component A) Page 7 of 9
MSDS 12/98
(continued)
PROPER SHIPPING NAME: Chemicals, N.O.I. (isocyanate, NMFC 60,000). Nonregulated
HAZARD CLASS OR DIVISION: None
UN/NA NUMBER: None
FREIGHT CLASS: 55
PACKAGING GROUP: None
HAZARDOUS SUBSTANCE: Methylene Diphenyl Diisocyanate
DOT PRODUCT RQ lbs.: 5000 lbs.
HAZARD PANEL(s): None
HAZARD PLACARD(s): None
? WHEN IN INDIVIDUAL CONTAINERS OF LESS THAN THE PRODUCT RQ, THIS
MATERIAL SHIPS AS NON-REGULATED.
IMO / IMDG CODE (OCEAN)
HAZARD CLASS DIVISION NUMBER: Non-regulated
ICAO / IATA (AIR)
HAZARD CLASS DIVISION NUMBER: Non-regulated
*********************SECTION XV ?REGULATORY INFORMATION**********************
OSHA STATUS: This product is hazardous under the criteria of the Federal OSHA Hazard
Communication Standard 29 CFR 1910.1200.
TSCA STATUS: On TSCA Inventory
CERCLA REPORTABLE QUANTITY: 5000 lbs. for 4,4'-Diphenylmethane Diisocyanate,
CAS # 101-68-8.
SARA TITLE III:
SECTION 302 EXTREMELY HAZARDOUS SUBSTANCES: None
SECTION 311/312 HAZARD CATEGORIES: Immediate Health Hazard; Delayed Health
Hazard; Reactive Hazard
SECTION 313 TOXIC CHEMICALS: Polymeric Diphenylmethane Diisocyanate,
CAS # 9016-87-9, 100%; Contained in this polymeric MDI product is 4,4'-Diphenylmethane
Diisocyanate, CAS # 101-68-8, Upper Bound 45%.
RCRA STATUS: MDI is not listed as a hazardous waste. To the best of our knowledge, MDI
does not meet the criteria of a hazardous waste if discarded in its purchased form. However,
under RCRA, it is the responsibility of the user of products to determine, at the time of
disposal, whether a product meets any of the criteria for a hazardous waste. This is because
product uses, transformations, mixtures, processes, etc., may render the resulting material
hazardous, under the criteria of ignitability, corrosivity, reactivity and toxicity characteristics
under the new Toxicity Characteristics Leaching Procedure (TCLP) 40 Code of Federal
Regulations 261.20-24.
The following chemicals are specifically listed by individual states; other product specific health
and safety data in other sections of the MSDS may also be applicable for state requirements.
For details on your regulatory requirements you should contact the appropriate agency in
your state.
Elastomer Series (Component A) Page 8 of 9
MSDS 12/98
(continued)
COMPONENT NAME
CAS NUMBER CONCENTRATION STATE CODE
4,4'-Diphenylmethane PA1, FL, IL, MA,
Diisocyanate (MDI) NJ1, NJ4, CN2
CAS # 101-68-8 Upper Bound 45%
Higher Oligomers of MDI PA3, NJ4
CAS # 9016-87-9 45-55%
Diphenylmethane PA3, NJ4
Diisocyanate (MDI)
CAS # 26447-40-5 1-10%
Phenyl isocyanate MA
CAS # 103-71-9 Trace - ppm
* FL Florida Substance List
IL Illinois Toxic Substance List
MA Massachusetts Hazardous Substance List
NJ1 New Jersey Hazardous Substance List
NJ4 New Jersey Other ?included in 5 predominant ingredients > 1%
PA1 Pennsylvania Hazardous Substance List
PA3 Pennsylvania Non-hazardous present at 3% or greater
RI Rhode Island List of Designated Substances
CN2 Canada WHMIS Ingredient Disclosure List over 0.1%
***********************SECTION XVI ?OTHER INFORMATION**************************
NFPA 704M RATINGS: Health Flammability Reactivity Other
3 1 1
0 ?Insignificant
1 ?Slight
2 ?Moderate
3 ?High
4 ?Extreme
HMIS RATINGS: Health Flammability Reactivity Other
3* 1 1
0 ?Minimal
1 ?Slight
2 ?Moderate
3 ?Serious
4 ?Severe
?Chronic Health Hazard
PREPARED BY: C. Boddie
APPROVAL DATE: 12/98
SUPERCEDES DATE: 06/97
Elastomer Series (Component A) Page 9 of 9
MSDS 12/98
(continued)
This information is furnished without warranty, expressed or implied, except that it is accurate to
the best knowledge of PRECISION CONVERTING The data on this sheet relates only to the
specific material designated herein. PRECISION CONVERTING assumes no legal
responsibility for use or reliance upon this data.
|